Holen Sie sich die Stockscreener-App
2.90
0.35%
0.010
Handel nachbörslich:
2.85
-0.05
-1.72%
Entera Bio Ltd Aktie (ENTX) Neueste Nachrichten
Entera Bio Ltd (ENTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement - MarketBeat
Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Increases By 286.7% - marketbeat.com
Entera Bio at Canaccord Genuity: oral osteoporosis push advances By Investing.com - Investing.com Canada
Entera Bio (ENTX) completes $275M Rule 506(b) private offering of shares and warrants - Stock Titan
Entera Bio shares slip as Q2 loss comes in wider than expected - Yahoo Finance
Entera Bio misses Q2 estimates, reports wider loss By Investing.com - Investing.com Nigeria
Entera Bio misses Q2 estimates, reports wider loss - Investing.com
Entera Bio Ltd. (ENTX) stock price, news, quote and history - au.finance.yahoo.com
Entera Bio (NASDAQ:ENTX) Upgraded to Sell at Wall Street Zen - marketbeat.com
Entera Bio (NASDAQ:ENTX) Announces Earnings Results - MarketBeat
Entera Bio Q2 EPS misses estimate as net loss widens to $7.3 million - scanx.trade
Entera Announces Second Quarter 2026 Financial Results and Business Updates - manilatimes.net
Entera Bio Reports Q2 2026 Loss and $275 Million Private Placement - Moomoo
Entera Bio Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Entera Bio (ENTX) awards 180,000 options to Chief of R&D - Stock Titan
Entera Q2 2026 earnings: Phase 3 preparation widened the loss - TradingKey
ENTX: FDA-aligned Phase 3 for EB613 and $275M financing secure pipeline progress and cash runway - TradingView
Entera Bio Ltd. Q2 2026: Revenue $0M, Net loss $7.31M, EPS ($0.14) — 10-Q Summary - TradingView
Entera Bio Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Entera Bio Sees Funding Sufficient Into 2030 >ENTX - Moomoo
Entera Bio Ltd (ENTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ENTX|Entera Bio Ltd|Price:2.890|Chg%:+0.020 - TradingKey
Entera Bio data selected for ASBMR plenary session - PharmaTimes
ENTX Q2'26 Earnings: EPS estimate is (0.08) USD - TradingView
Entera Bio (ENTX): Longitude entities report 4.6% ownership, Seven Fleet 4.1% - Stock Titan
Entera Bio (NASDAQ:ENTX) Trading Down 2.1%Here's What Happened - marketbeat.com
BVF Partners Wins Board Designation Rights at Entera Bio with 9.99% Stake - TradingView
Seven Fleet funds disclose 4.1% Entera Bio (ENTX) stake and shared voting power - stocktitan.net
Entera Bio (ENTX) sees BVF build 9.99% stake after $275M financing - Stock Titan
Entera Bio (ENTX) stake of 12.25M shares reported by TCG Crossover - stocktitan.net
Vivo Opportunity group (NASDAQ: ENTX) discloses 12.3M-share holding in Entera Bio - Stock Titan
Entera Bio’s EB613 data selected for plenary poster at ASBMR - Investing.com
Entera Bio Ltd. (IL0011429839.SG) Stock Forum & Discussion - Yahoo! Finance Canada
Entera Bio’s EB613 data selected for plenary poster at ASBMR By Investing.com - Investing.com Australia
Entera Bio’s oral bone-building candidate selected for ASBMR plenary - Stock Titan
Entera Bio Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Weekly Recap: Entera Bio $275M placement and director resignations - TradingView
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Entera Bio CEO Miranda Toledano to speak at Canaccord Genuity conference - scanx.trade
Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE - marketscreener.com
Why the World's Leading Healthcare Funds All Wanted a Piece of Entera Bio (NASDAQ: ENTX) - TradingView
Entera Bio raises $275M in oversubscribed placement, shares rebound on funding news - scanx.trade
Entera Bio Raises $275 Million in Market-Priced Private Placement Led by BVF - TradingView
ENTX|Entera Bio Ltd|Price:3.930|Chg%:+1.880 - TradingKey
Entera Bio Ltd. announced that it expects to receive $274.999977 million in funding from a group of investors - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Entera Bio Shares Climb on $275M Private Placement - Moomoo
Entera Bio Ltd (ENTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Entera Bio stock surges on $275M private placement By Investing.com - Investing.com Nigeria
Entera Bio raises $275m for Phase III osteoporosis drug trialGlobes - Globes - Israel Business News
Entera Bio raises $275 million in private placement for phase 3 - Investing.com
ENTX Stock Explodes Higher As Traders Pounce On Breakout - StocksToTrade
Entera Bio stock surges on $275M private placement - Investing.com
Entera Bio raises $275 million in private placement - Investing.com
Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement - TradingView
Entera Bio raises $275 million in private placement By Investing.com - Investing.com Canada
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement - Yahoo Finance
Entera Bio Ltd (ENTX) Cash Flow - TradingKey
Entera Bio Ltd (ENTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Entera Bio Ltd (ENTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):